Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLT
4426
DELISTED
Applied Therapeutics
APLT
| $63.1K | ﹤0.01% |
129,084
-42,931
| -25% | -$25.3K |
|
4427
Amplify Mobile Payments ETF
IPAY
$170M
| $62.9K | ﹤0.01% |
1,182
| – | – |
|
4428
PUT
Virgin Galactic
SPCE
$328M
| $62.7K | ﹤0.01% |
+20,700
| New | +$90.8K |
|
4429
Protalix BioTherapeutics
PLX
$191M
| $62.2K | ﹤0.01% |
24,310
-10,013
| -29% | -$23.9K |
|
4430
Sumitomo Mitsui Financial
SMFG
$164B
| $61.8K | ﹤0.01% |
4,000
| – | – |
|
4431
Genmab
GMAB
$17.7B
| $61.8K | ﹤0.01% |
3,154
+656
| +26% | +$13.8K |
|
|
NOAH
4432
Noah Holdings
NOAH
$580M
| $61.7K | ﹤0.01% |
6,524
-22,136
| -77% | -$242K |
|
4433
PUT
AB InBev
BUD
$170B
| $61.6K | ﹤0.01% |
1,000
| – | – |
|
4434
Immunic
IMUX
$190M
| $61.4K | ﹤0.01% |
5,629
-2,801
| -33% | -$30.2K |
|
4435
iShares Global Consumer Discretionary ETF
RXI
$260M
| $61.1K | ﹤0.01% |
344
| – | – |
|
4436
GrowGeneration
GRWG
$86.5M
| $60.9K | ﹤0.01% |
56,423
-28,105
| -33% | -$37.7K |
|
|
LSB
4437
DELISTED
LakeShore Biopharma
LSB
| $60.7K | ﹤0.01% |
24,757
| – | – |
|
4438
iShares MSCI Indonesia ETF
EIDO
$480M
| $60.3K | ﹤0.01% |
3,700
| – | – |
|
|
ZYXI
4439
DELISTED
Zynex
ZYXI
| $60K | ﹤0.01% |
27,259
-5,569
| -17% | -$36.3K |
|
4440
Inovio Pharmaceuticals
INO
$55.7M
| $59.3K | ﹤0.01% |
36,409
-2,705
| -7% | -$5.43K |
|
4441
Brown-Forman Class A
BF.A
$13.4B
| $59.2K | ﹤0.01% |
1,770
+954
| +117% | +$32K |
|
4442
NET Power
NPWR
$126M
| $58.5K | ﹤0.01% |
22,236
-10,115
| -31% | -$71.4K |
|
4443
Traeger
COOK
$178M
| $58.4K | ﹤0.01% |
696
-344
| -33% | -$38.1K |
|
4444
InnovAge Holding
INNV
$1.54B
| $58.4K | ﹤0.01% |
19,593
-9,506
| -33% | -$32.8K |
|
4445
iShares MSCI Malaysia ETF
EWM
$310M
| $57.7K | ﹤0.01% |
2,500
| – | – |
|
4446
VirTra
VTSI
$34.9M
| $57.6K | ﹤0.01% |
14,148
-3,127
| -18% | -$18.7K |
|
4447
Cenovus Energy
CVE
$55.7B
| $57.4K | ﹤0.01% |
4,123
-5,068
| -55% | -$73K |
|
|
SWKH
4448
DELISTED
SWK Holdings
SWKH
| $57.2K | ﹤0.01% |
4,153
-2,098
| -34% | -$27.6K |
|
4449
Mastech Digital
MHH
$93.1M
| $57.2K | ﹤0.01% |
5,601
-2,519
| -31% | -$30.8K |
|
4450
Ispire Technology
ISPR
$83.2M
| $57K | ﹤0.01% |
20,888
-9,563
| -31% | -$40.4K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.